Growing community of inventors

Rensselaer, NY, United States of America

Muralikrishna Valluri

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Muralikrishna ValluriLouis Nickolaus Jungheim (4 patents)Muralikrishna ValluriKenneth Jeff Thrasher (4 patents)Muralikrishna ValluriRobert Jason Herr (4 patents)Muralikrishna ValluriJohn Mcneill McGill, Iii (2 patents)Muralikrishna ValluriJohn McNeil McGill (2 patents)Muralikrishna ValluriJohn Mcneill Mcgill (2 patents)Muralikrishna ValluriMuralikrishna Valluri (4 patents)Louis Nickolaus JungheimLouis Nickolaus Jungheim (29 patents)Kenneth Jeff ThrasherKenneth Jeff Thrasher (29 patents)Robert Jason HerrRobert Jason Herr (19 patents)John Mcneill McGill, IiiJohn Mcneill McGill, Iii (5 patents)John McNeil McGillJohn McNeil McGill (4 patents)John Mcneill McgillJohn Mcneill Mcgill (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Emisphere Technologies, Inc. (4 from 183 patents)


4 patents:

1. 8765796 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

2. 8552039 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

3. 8546581 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide

4. 7662771 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…